Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 6/20 | 0.63 |
| ▸ | CA1 | P00915 | 6/20 | 0.63 |
| ▸ | CA2 | P00918 | 6/20 | 0.63 |
| ▸ | CA7 | P43166 | 6/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.58 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27683331 | 0.92 | RAB9A (0.62) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL30678268 | 0.92 | NPC1 (0.62) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL6233392 | 0.92 | NPC1 (0.62) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL23471093 | 0.91 | NPC1 (0.56) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL820795 | 0.89 | NPC1 (0.55) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL161684 | 0.88 | CA12 (0.67) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL6057062 | 0.88 | RAB9A (0.58) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL161683 | 0.88 | NPC1 (0.58) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL16077013 | 0.87 | SMN1; SMN2 (0.56) | NPC1RAB9ASMN1; SMN2HTTMAPT | |
| SCHEMBL6569149 | 0.87 | NPC1 (0.56) | NPC1RAB9ASMN1; SMN2HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478563-B | Method for rapidly crystallizing isosorbide | 国科温州研究院(温州生物材料与工程研究所) | 2023-09-29 | — | — | CN | claimed |
| CN-114478563-A | Method for quickly crystallizing isosorbide | 国科温州研究院(温州生物材料与工程研究所) | 2022-05-13 | — | — | CN | claimed |
| US-20080171659-A1 | Insecticidally Coated Fertilizer Solids | ETIGRA | 2008-07-17 | — | — | US | claimed |
| US-6703339-B2 | COORIDNATION CATALYST | CHINA PETRO-CHEMICAL CORPORATION (CN) | 2004-03-09 | — | — | US | claimed |
| US-20020010081-A1 | Components and catalysts for the (co) polymerization of olefins | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, SINOPEC, JOINTLY (CN) | 2002-01-24 | — | — | US | claimed |
| EP-2658541-B2 | TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL | INTERVET INT BV (NL) | 2025-12-17 | — | — | EP | disclosed |
| EP-4613096-A2 | ANTIPARASITIC COMPOUNDS | Intervet International B.V. (NL) | 2025-09-10 | — | — | EP | disclosed |
| US-12390450-B2 | Antiparasitic pour-on compositions | INTERVET INC. (US) | 2025-08-19 | — | — | US | disclosed |
| EP-2658542-B2 | TOPICAL LOCALIZED ISOXAZOLINE FORMULATION | INTERVET INT BV (NL) | 2025-06-04 | — | — | EP | disclosed |
| EP-4559482-A2 | ANTIPARASITIC POUR-ON COMPOSITIONS | Intervet International B.V. (NL) | 2025-05-28 | — | — | EP | disclosed |
| EP-3727375-B1 | ANTIPARASITIC POUR-ON COMPOSITIONS | INTERVET INT BV (NL) | 2025-03-19 | — | — | EP | disclosed |
| US-20240315993-A1 | ANTIPARASITIC COMPOUNDS | INTERVET INC. (US) | 2024-09-26 | — | — | US | disclosed |
| EP-0039155-B1 | POLYESTER MOLDING COMPOSITION, PRODUCTION THEREOF AND MOLDED ARTICLES PRODUCED THEREFROM | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-10-09 | — | — | EP | disclosed |
| US-4524191-A | AN AROMATIC POLYAMIDE NUCLEATING AGENT TO ACCELERATE THE CRYSTALLIZATION OF POLYT YLENE TEREPHTLATE DURING INJECTION MOLDING | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-06-18 | — | — | US | disclosed |
| US-4440920-A | ISOPHTHALIC OR TEREPHTHALIC ACID WITH BIS/HYDROXYPHENYL/ SULFONE AND 2,2-BIS/4-HYDROXYPHENYL/PROPANE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1984-04-03 | — | — | US | disclosed |
| US-4417021-A | POLYAMIDES, POLYHYDRAZIDES AS NUCLEATION AGENTS, MOLDING | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1983-11-22 | — | — | US | disclosed |
| EP-0077834-A1 | AROMATIC POLYESTER | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1983-05-04 | — | — | EP | disclosed |
| EP-0039155-A1 | Polyester molding composition, production thereof and molded articles produced therefrom | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1981-11-04 | — | — | EP | disclosed |
| US-4107150-A | High impact terephthalate copolyesters using 1,4-butanediol and 1,4-cyclohexanedimethanol | PHILLIPS PETROLEUM COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
| US-4049635-A | TRANSESTERIFICATION | PHILLIPS PETROLEUM COMPANY (US) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390450-B2 | Antiparasitic pour-on compositions | PIGS, ARG1, ARG2 | NPC1 1722/4885RAB9A 3227/4885SMN1; SMN2 2465/4885 |
| US-20240315993-A1 | ANTIPARASITIC COMPOUNDS | PIGO, CAT, CYP51A1 | NPC1 733/4885RAB9A 1543/4885SMN1; SMN2 2653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.